The latest price target for OKYO Pharma (NASDAQ: OKYO) was reported by HC Wainwright & Co. on November 2, 2023. The analyst firm set a price target for $4.00 expecting OKYO to rise to within 12 months (a possible 153.16% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for OKYO Pharma (NASDAQ: OKYO) was provided by HC Wainwright & Co., and OKYO Pharma initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OKYO Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OKYO Pharma was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.

While ratings are subjective and will change, the latest OKYO Pharma (OKYO) rating was a initiated with a price target of $0.00 to $4.00. The current price OKYO Pharma (OKYO) is trading at is $1.58, which is within the analyst's predicted range.